European Penny Stocks: 3 Picks With Market Caps Over €40M

Simply Wall St

Mon, April 6, 2026 at 2:05 AM EDT 4 min read

The European market has recently experienced a wave of optimism, with the STOXX Europe 600 Index climbing nearly 4% amid hopes for a shorter-than-expected conflict in the Middle East. As investors navigate these turbulent times, penny stocks—often seen as relics of past trading days—still present relevant opportunities for growth. These smaller or newer companies can offer significant returns when supported by strong financial health and solid fundamentals, making them an intriguing option for those seeking hidden value in today’s market landscape.

Click here to see the full list of 284 stocks from our European Penny Stocks screener.

We’ll examine a selection from our screener results.

Simply Wall St Financial Health Rating: ★★★★★☆

Overview: AROBS Transilvania Software S.A. offers customized software services across Romania, Europe, the United States, Asia, and the Middle East with a market capitalization of RON689.18 million.

Operations: AROBS Transilvania Software S.A. has not reported any specific revenue segments.

Market Cap: RON689.18M

AROBS Transilvania Software S.A. demonstrates a strong financial position with more cash than total debt, and its operating cash flow covers its debt well. Recent earnings results show significant growth, with net income rising to RON 31.35 million and revenue increasing to RON 447.81 million for the year ended December 2025. Despite this positive trajectory, AROBS’s return on equity remains low at 6.6%. The company’s short-term assets comfortably cover both short-term and long-term liabilities, indicating solid liquidity management while maintaining stable weekly volatility over the past year at 4%.

• Take a closer look at AROBS Transilvania Software’s potential here in our financial health report.

• Evaluate AROBS Transilvania Software’s prospects by accessing our earnings growth report.

Simply Wall St Financial Health Rating: ★★★★★☆

Overview: Fermentalg SA develops biosolutions using aquatic micro-organisms for various markets globally, with a market cap of €46.38 million.